1. Home
  2. INO

INO

Inovio Pharmaceuticals Inc.

Logo Inovio Pharmaceuticals Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Founded: 1979 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 271.8M IPO Year: 1998
Target Price: $21.00 AVG Volume (30 days): 490.9K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -6.09 EPS Growth: N/A
52 Week Low/High: $3.84 - $14.75 Next Earning Date: 05-08-2024
Revenue: $832,010 Revenue Growth: -91.89%
Revenue Growth (this year): -26.65% Revenue Growth (next year): 1062.65%

Share on Social Networks: